Search

Your search keyword '"Andersen, Steen"' showing total 10 results
Start Over Author "Andersen, Steen" Language english Journal diabetes care
10 results on '"Andersen, Steen"'

7. Comparative effects of Irbesartan on ambulatory and office blood pressure. (Original Article: Clinical Care/Education/Nutrition)

Author

Rossing, Kasper, Christensen, Per K., Andersen, Steen, Hovind, Peter, Hansen, Henrik Post, and Parving, Hans-Henrik

Subjects
Blood pressure -- Physiological aspects -- Measurement, Irbesartan -- Physiological aspects -- Measurement, Type 2 diabetes -- Physiological aspects -- Measurement, Health, Physiological aspects, Measurement
Abstract

A substudy of ambulatory blood pressure from the Irbesartan in patients with type 2 diabetes and microalbuminuria study. OBJECTIVE--Irbesartan was renoprotective independently of its blood pressure-lowering effect in the Irbesartan [...]

Published
2003

9. Improved Time in Range Over 1 Year Is Associated With Reduced Albuminuria in Individuals With Sensor-Augmented Insulin Pump-Treated Type 1 Diabetes.

Author

Ranjan, Ajenthen G., Rosenlund, Signe V., Hansen, Tine W., Rossing, Peter, Andersen, Steen, and Nørgaard, Kirsten

Subjects
TYPE 1 diabetes, ALBUMINURIA, GLYCOSYLATED hemoglobin, INSULIN pumps, INSULIN, BLOOD sugar analysis, RESEARCH, TIME, BLOOD sugar monitoring, RESEARCH methodology, HYPOGLYCEMIC agents, MEDICAL cooperation, EVALUATION research, TREATMENT effectiveness, COMPARATIVE studies, CREATININE, LONGITUDINAL method, DISEASE complications
Abstract

Objective: To investigate the association between treatment-induced change in continuous glucose monitoring (CGM) time in range (TIR) and albuminuria in persons with type 1 diabetes (T1D) treated with sensor-augmented insulin pumps (SAP).Research Design and Methods: Twenty-six out of 55 participants with albuminuria and multiple daily injection therapy (25% females; median 51 [interquartile range 46-63] years of age; glycated hemoglobin A1c (HbA1c) 75 [68-88] mmol/mol [9.0% (8.4-10.4%)]; and urinary albumin-to-creatinine ratio (UACR) 89 [37-250] mg/g) were in a randomized controlled trial assigned to SAP therapy for 1 year. Anthropometrics, CGM data, and blood and urine samples were collected every 3 months.Results: Mean change (95% CI) in percentage of TIR (%TIR) was 13.2% (6.2; 20.2), in HbA1c was -14.4 (-17.4; -10.5) mmol/mol (-1.3% [-1.6; -1.0]), and in UACR was -15% (-38; 17) (all P < 0.05). UACR decreased by 19% (10; 28) per 10% increase in %TIR (P = 0.04), 18% (1; 30) per 10 mmol/mol decrease in HbA1c (P = 0.07), and 31% per 10-mmHg decrease in mean arterial pressure (P < 0.001).Conclusions: In this longitudinal study, treatment-induced increase in %TIR was significantly associated with decrease in albuminuria in T1D. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

10. Kidney function during and after withdrawal of long-term irbesartan treatment in patients with type 2 diabetes and microalbuminuria

Author

Kaiser, Thomas, Florack, Christiane, Sawicki, Peter T., Andersen, Steen, Brochner-Mortensen, Jens, and Parving, Hans-Henrik

Subjects
Irbesartan -- Research -- Complications and side effects, Glomerular filtration rate -- Research, Type 2 diabetes -- Care and treatment -- Research -- Complications and side effects, Health, Care and treatment, Complications and side effects, Research
Abstract

Response to Andersen, Brochner-Mortensen, and Parving We read with great interest the article by Andersen, Brochner-Mortensen, and Parving (1) about the effects of long-term treatment with irbesartan on kidney function [...]

Published
2004

Catalog

Books, media, physical & digital resources
See catalog results